UroViu Receives CE Certification of Its Wi-Fi Enabled Cystoscope and Hysteroscope Product Portfolio

Audio By Carbonatix

LOS ALTOS, Calif.--(BUSINESS WIRE)--Nov 6, 2025--

UroViu Corporation announced today that it has received CE certification for its cystoscope and hysteroscope product portfolio. This includes the reusable UV5000w Wi-Fi Handle and the disposable Hystero-V, Uro-V, and Uro-GHD endoscopes.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251105615011/en/

"This CE certification is a significant milestone for UroViu and will enable us to offer our versatile, portable, and environmentally friendly endoscopy portfolio to patients in all regions that accept the CE Marking worldwide," said Bruce OuYang, Ph.D., CEO. "The UV5000w platform represents a major advancement in endoscopy, allowing clinicians to maintain their line of sight during procedures while providing secure wireless connectivity and simultaneous external display for patient and additional clinician viewing.”

The UroViu portfolio has been widely adopted across various segments of the U.S. Urology and UroGynecology market, including private practices, Ambulatory Surgical Centers (ASCs), academic institutions, VA, and DOD healthcare facilities. UroViu products offer several unique features ideal for offices and outpatient clinics:

• Self-Contained, Cordless, Untethered Design: This design minimizes environmental impact and the carbon footprint of disposable products by eliminating the need for peripherals. The profile and weight of all our disposable products are half to a third compared to similar products on the market.
• Portability and Simplicity: The UV5000w transforms any room into a procedure room, allowing for schedule expansion and creating workflow efficiencies that benefit both practices and patients.
• Versatile Platform: The UV400 platform facilitates the rapid addition of single-use cannulas optimized for a variety of indications, providing flexibility for healthcare providers without requiring investment in additional reusable devices.

Data presented at recent meetings of the EAU and AUA demonstrate the clinical value and efficiency of UroViu’s portfolio for cystoscopy procedures, including diagnosis, cancer surveillance, and other simple therapeutic procedures.

For more information on international distribution outside of the USA or to schedule a hands-on demonstration, please contact UroViu's sales representatives or customer service as listed on our website: https://www.uroviu.com.

UroViu Corp, based in Los Altos, California, develops, manufactures, and commercializes advanced single-use endoscopic visualization solutions worldwide. The company pioneered the world's most portable cystoscopy platform that is always ready, eliminating the need for reprocessing, capital equipment, servicing, and advance scheduling. UroViu's mission is to simplify workflows and expand access to high-quality endoscopy by integrating cutting-edge technologies, including edge AI and robotics.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251105615011/en/

CONTACT: Media contact:

Email:[email protected]

Office: (650) 451-7746

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: ROBOTICS MEDICAL DEVICES HEALTH TECHNOLOGY HEALTH TECHNOLOGY HARDWARE

SOURCE: UroViu Corporation

Copyright Business Wire 2025.

PUB: 11/06/2025 03:00 PM/DISC: 11/06/2025 03:00 PM

http://www.businesswire.com/news/home/20251105615011/en